Der chinesische Menschenversuch

Donnerstag 21.3.2019

Die WHO ist auch gegen einen Bann, ein Register soll es richten.

“The committee agrees it is irresponsible at this time for anyone to proceed with clinical applications of human germline genome editing,” said Margaret Hamburg, the panel’s co-chair and foreign secretary of the US National Academy of Medicine. But she emphasized that the WHO panel is not calling for a permanent moratorium on such research. “We are trying to look at the broader picture and a framework for responsible stewardship,” said Hamburg, a former commissioner of the US Food and Drug Administration. “I don’t think a vague moratorium is the answer for what needs to be done.”